|
1.
|
Details of PDMR/person closely associated with them
('PCA')
|
|||
|
a)
|
Name
|
Dr K
Slaoui
|
||
|
b)
|
Position/status
|
PCA of
Dr M M Slaoui (Chairman, Global Vaccines)
|
||
|
c)
|
Initial
notification/
amendment
|
Initial
notification
|
||
|
2.
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
|||
|
a)
|
Name
|
GlaxoSmithKline
plc
|
||
|
b)
|
LEI
|
5493000HZTVUYLO1D793
|
||
|
3.
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transaction(s) has been
conducted
|
|||
|
a)
|
Description
of the financial instrument
|
GlaxoSmithKline
plc American Depositary Shares ('ADSs')
ISIN:
US37733W1053
|
||
|
b)
|
Nature
of the transaction
|
An
increase of 1 ADS following the notional allocation of ADSs on 15
September 2016, at a price of $43.54 per ADS, as a result of the
revaluation of the cash element of the notional investment held
within the GSK 401(K) plan.
|
||
|
c)
|
Price(s)
and
volume(s)
|
Price(s)
|
Volume(s)
|
|
|
$43.54
|
1
|
|||
|
d)
|
Aggregated
information
Aggregated
volume Price
|
n/a
(single transaction)
|
||
|
e)
|
Date of
the transaction
|
2016-09-15
|
||
|
f)
|
Place
of the transaction
|
n/a
|
||